ASCO Annual Meeting: Best of Hematology | Conference

Julie Vose, MD, MBA, Discusses Novel Treatment Options for Hematologic Malignancies
July 29, 2021

Julie Vose, MD, MBA, a professor of internal medicine in the Division of Oncology and Hematology at the University of Nebraska Medical Center, discusses novel treatment options for patients with hematologic malignancies at the 2021 American Society of Clinical Oncology Annual Meeting.

Julie Vose, MD, MBA, on the Use of CAR T-Cell Therapy in Lymphomas
July 28, 2021

Julie Vose, MD, MBA, a professor of internal medicine in the Division of Oncology and Hematology at the University of Nebraska Medical Center discussed the benefits of CAR T-cell for patients with follicular lymphoma.

Julie Vose, MD, MBA, Discussed Toxicities Associated With Acalabrutinib or Ibrutinib for Chronic Lymphocytic Leukemia
July 27, 2021

CancerNetwork® sat down with Julie Vose, MD, MBA, at the 2021 American Society of Clinical Oncology Annual Meeting to talk about a clinical trial comparing acalabrutinib versus ibrutinib for patients with chronic lymphocytic leukemia.